Market Tracker

04/23 1:10pm ET

Heron Therapeutics Inc (NASDAQ:HRTX)

30.60
Delayed Data
As of 12:55pm ET
 +0.75 / +2.51%
Today’s Change
12.70
Today|||52-Week Range
32.70
+69.06%
Year-to-Date
No recent news for Heron Therapeutics Inc.

Today’s Trading

Previous close29.85
Today’s open31.00
Day’s range30.05 - 31.10
Volume353,020
Average volume (3 months)1,243,614
Market cap$1.5B
Data as of 12:55pm ET, 04/23/2018

Growth & Valuation

Earnings growth (last year)+20.05%
Earnings growth (this year)+30.24%
Earnings growth (next 5 years)+47.80%
Revenue growth (last year)+2,305.55%
P/E ratioNM
Price/Sales31.79
Price/Book11.21

Competitors

 Today’s
change
Today’s
% change
ADROAduro Biotech Inc+0.15+2.16%
BYSIBeyondspring Inc-1.40-4.50%
ZIOPZIOPHARM Oncology In...+0.05+1.16%
TGTXTG Therapeutics Inc-0.55-3.82%
Data as of 1:10pm ET, 04/23/2018

Financials

Next reporting dateMay 11, 2018
EPS forecast (this quarter)-$0.64
Annual revenue (last year)$30.8M
Annual profit (last year)-$197.5M
Net profit margin-641.87%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Barry D. Quart
President, Director &
Chief Commercial Officer
Robert H. Rosen
Corporate headquarters
San Diego, California

Forecasts